Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Ozden Rabia Gurses. Officer active across 2 companies, notably Ocular Therapeutix, INC. Aggregated, 8 disclosures have been logged. Split: 0 buy · 3 sells. Total volume traded: €64k. Activity tracked since 1 July 2022. The latest transaction was disclosed on 25 February 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Ozden Rabia Gurses is a declarant linked to Ocular Therapeutix, INC and Adverum Biotechnologies, Inc., where the listed role is Chief Medical Officer. She has 8 filings in total, and across the 8 recent filings available, reported sell transactions total 64419 EUR, with a date range from 2022-07-15 to 2025-12-10; the stated transaction nature is Attribution.